장관 관리 시스템 시장 : 세계 규모, 점유율, 동향 분석, 기회, 예측 보고서(2019-2030년)

Global Bowel Management Systems Market Size Expands at Healthy CAGR of 4.98% to Touch USD 3.24 Billion by 2030

Global Bowel Management Systems Market is expanding rapidly due to the rising prevalence of gastrointestinal disorders, aging population, growing adoption of technological advancements, increasing healthcare awareness, and growing demand for minimally invasive procedures.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Bowel Management Systems Market size by value at USD 2.76 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Bowel Management Systems Market size to expand at a CAGR of 4.98% reaching a value of USD 3.24 billion in 2023. The growth of the Global Bowel Management Systems Market is driven by the increasing prevalence of bowel disorders, the rising geriatric population, and higher awareness about advanced treatment options. Additionally, technological advancements in bowel management devices, growing healthcare expenditures, and supportive government initiatives enhance market expansion. Factors like improved diagnostic tools, better patient outcomes, and the rising incidence of fecal incontinence also contribute to market demand. Enhanced product availability, a surge in minimally invasive procedures, and a heightened focus on patient comfort further stimulate market growth.

Opportunity - Increasing level of disposable incomes

The Global Bowel Management Systems Market is expected to witness significant growth, driven by rising disposable incomes in developing countries. As household incomes increase, more individuals can afford advanced medical treatments and healthcare services. This economic uplift enables greater access to bowel management systems, improving the quality of life for patients with gastrointestinal disorders. Additionally, enhanced healthcare infrastructure and increased awareness of bowel health contribute to the market expansion. The growing middle class in these regions is expected to further stimulate demand, solidifying the market's robust growth trajectory.

Impact of Escalating Geopolitical Tensions on Global Bowel Management Systems Market

Escalating geopolitical tensions can significantly impact the Global Bowel Management Systems Market by disrupting supply chains and increasing costs. Key regions like Europe and Asia Pacific, crucial for manufacturing and distribution, face instability, causing delays and price surges in raw materials and components. The Russia-Ukraine conflict exemplifies this, as sanctions and logistical challenges hinder market operations. Additionally, heightened trade barriers and regulatory uncertainties deter investments and innovations in the healthcare sector. For instance, trade wars between major economies such as the United States and China can lead to restricted access to essential technologies and materials, further straining market growth. These factors collectively slow down product development and market expansion, ultimately affecting the availability and affordability of bowel management systems globally.

Global Bowel Management Systems Market

Segmental Coverage

Global Bowel Management Systems Market - By Product Type

Based on product type, Global Bowel Management Systems Market is divided into Irrigation Systems, Colostomy Bags, Nerve Modulation Devices, and Accessories segments. The colostomy bags segment dominates the market by product type due to the high prevalence of colorectal cancer and inflammatory bowel diseases, which often necessitate colostomy procedures. Additionally, the rising awareness and acceptance of colostomy as a viable management solution contribute to its market leadership. The convenience, improved quality of life for patients, and advancements in colostomy bag technology further bolster their dominance in the Global Bowel Management Systems Market.

Global Bowel Management Systems Market - By Patient Type

By patient type, Global Bowel Management Systems Market is split into Adult and Pediatric segments. The adult segment holds a larger share of the market. The segment's dominance is attributed to the higher prevalence of bowel disorders among the adult population, increasing awareness about bowel management solutions, and the greater adoption of advanced medical technologies in this demographic. Additionally, the aging population, which is more prone to conditions, such as fecal incontinence and chronic constipation, further boosts the demand in the adult segment, making it the largest contributor to the market's overall growth and revenue.

Competitive Landscape

Global Bowel Management Systems Market is fiercely competitive. Major companies in the market include Coloplast, Medtronic, Convatec, Hollister Incorporated, B. Braun Melsungen AG, Axonics Inc, Dentsply Sirona, Consure Medical, MBH-International A/S, and Renew Medical Inc. These companies use various strategies, including increasing investments in their R&D activities, mergers and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in the Global Bowel Management Systems Market.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the Global Bowel Management Systems Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Bowel Management Systems Market and industry insights to help decision makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

• 1.1. Research Objective
• 1.2. Product Overview
• 1.3. Market Segmentation

2. Executive Summary

3. Global Bowel Management Systems Market Insights

• 3.1. Industry Value Chain Analysis
• 3.2. DROC Analysis
  • 3.2.1. Growth Drivers
    • 3.2.1.1. Expanding target patient population
    • 3.2.1.2. Rapidly growing geriatric population
    • 3.2.1.3. Availability of technologically advanced bowel management products
    • 3.2.1.4. Favorable reimbursement scenario in developed countries
  • 3.2.2. Restraints
    • 3.2.2.1. High cost of bowel management systems
    • 3.2.2.2. Stigma associated with fecal incontinence
    • 3.2.2.3. Lack of awareness about bowel management systems
  • 3.2.3. Opportunities
    • 3.2.3.1. Rising disposable incomes in developing countries
    • 3.2.3.2. Increasing focus on home care
    • 3.2.3.3. Development of new and innovative products
  • 3.2.4. Challenges
    • 3.2.4.1. Reimbursement challenges
    • 3.2.4.2. Stringent regulatory requirements
    • 3.2.4.3. Competition from generic products
• 3.3. Technological Advancements/Recent Developments
• 3.4. Regulatory Framework
• 3.5. Porter's Five Forces Analysis
  • 3.5.1. Bargaining Power of Suppliers
  • 3.5.2. Bargaining Power of Buyers
  • 3.5.3. Threat of New Entrants
  • 3.5.4. Threat of Substitutes
  • 3.5.5. Intensity of Rivalry

4. Global Bowel Management Systems Market: Marketing Strategies

5. Global Bowel Management Systems Market: Pricing Analysis

6. Global Bowel Management Systems Market: Geography Analysis

• 6.1. Global Bowel Management Systems Market, Geographical Analysis, 2023
• 6.2. Global Bowel Management Systems Market Attractiveness Analysis, 2024-2030

7. Global Bowel Management Systems Market Overview

• 7.1. Market Size & Forecast, 2019-2030
  • 7.1.1. By Value (USD Billion)
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
    • 7.2.1.1. Irrigation Systems
    • 7.2.1.2. Colostomy Bags
    • 7.2.1.3. Nerve Modulation Devices
    • 7.2.1.4. Accessories
  • 7.2.2. By Patient Type
    • 7.2.2.1. Adult
    • 7.2.2.2. Pediatric
  • 7.2.3. By End User
    • 7.2.3.1. Hospitals
    • 7.2.3.2. Ambulatory Surgical Centers
    • 7.2.3.3. Home Care Settings
    • 7.2.3.4. Specialty Clinics
  • 7.2.4. By Indication
    • 7.2.4.1. Chronic Constipation
    • 7.2.4.2. Fecal Incontinence
    • 7.2.4.3. Irritable Bowel Syndrome
    • 7.2.4.4. Colorectal Cancer
  • 7.2.5. By Country
    • 7.2.5.1. North America
    • 7.2.5.2. Europe
    • 7.2.5.3. Asia Pacific (APAC)
    • 7.2.5.4. Latin America (LATAM)
    • 7.2.5.5. Middle East and Africa (MEA)

8. North America Bowel Management Systems Market

• 8.1. Market Size & Forecast, 2019-2030
  • 8.1.1. By Value (USD Billion)
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Patient Type
  • 8.2.3. By End User
  • 8.2.4. By Indication
  • 8.2.5. By Country
    • 8.2.5.1. United States
    • 8.2.5.1.1. By Product Type
    • 8.2.5.1.2. By Patient Type
    • 8.2.5.1.3. By End User
    • 8.2.5.1.4. By Indication
    • 8.2.5.2. Canada
    • 8.2.5.2.1. By Product Type
    • 8.2.5.2.2. By Patient Type
    • 8.2.5.2.3. By End User
    • 8.2.5.2.4. By Indication

9. Europe Bowel Management Systems Market

• 9.1. Market Size & Forecast, 2019-2030
  • 9.1.1. By Value (USD Billion)
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Patient Type
  • 9.2.3. By End User
  • 9.2.4. By Indication
  • 9.2.5. By Country
    • 9.2.5.1. Germany
    • 9.2.5.1.1. By Product Type
    • 9.2.5.1.2. By Patient Type
    • 9.2.5.1.3. By End User
    • 9.2.5.1.4. By Indication
    • 9.2.5.2. United Kingdom
    • 9.2.5.2.1. By Product Type
    • 9.2.5.2.2. By Patient Type
    • 9.2.5.2.3. By End User
    • 9.2.5.2.4. By Indication
    • 9.2.5.3. Italy
    • 9.2.5.3.1. By Product Type
    • 9.2.5.3.2. By Patient Type
    • 9.2.5.3.3. By End User
    • 9.2.5.3.4. By Indication
    • 9.2.5.4. France
    • 9.2.5.4.1. By Product Type
    • 9.2.5.4.2. By Patient Type
    • 9.2.5.4.3. By End User
    • 9.2.5.4.4. By Indication
    • 9.2.5.5. Spain
    • 9.2.5.5.1. By Product Type
    • 9.2.5.5.2. By Patient Type
    • 9.2.5.5.3. By End User
    • 9.2.5.5.4. By Indication
    • 9.2.5.6. Belgium
    • 9.2.5.6.1. By Product Type
    • 9.2.5.6.2. By Patient Type
    • 9.2.5.6.3. By End User
    • 9.2.5.6.4. By Indication
    • 9.2.5.7. Russia
    • 9.2.5.7.1. By Product Type
    • 9.2.5.7.2. By Patient Type
    • 9.2.5.7.3. By End User
    • 9.2.5.7.4. By Indication
    • 9.2.5.8. The Netherlands
    • 9.2.5.8.1. By Product Type
    • 9.2.5.8.2. By Patient Type
    • 9.2.5.8.3. By End User
    • 9.2.5.8.4. By Indication
    • 9.2.5.9. Rest of Europe
    • 9.2.5.9.1. By Product Type
    • 9.2.5.9.2. By Patient Type
    • 9.2.5.9.3. By End User
    • 9.2.5.9.4. By Indication

10. Asia Pacific Bowel Management Systems Market

• 10.1. Market Size & Forecast, 2019-2030
  • 10.1.1. By Value (USD Billion)
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Patient Type
  • 10.2.3. By End User
  • 10.2.4. By Indication
  • 10.2.5. By Country
    • 10.2.5.1. China
    • 10.2.5.1.1. By Product Type
    • 10.2.5.1.2. By Patient Type
    • 10.2.5.1.3. By End User
    • 10.2.5.1.4. By Indication
    • 10.2.5.2. India
    • 10.2.5.2.1. By Product Type
    • 10.2.5.2.2. By Patient Type
    • 10.2.5.2.3. By End User
    • 10.2.5.2.4. By Indication
    • 10.2.5.3. Japan
    • 10.2.5.3.1. By Product Type
    • 10.2.5.3.2. By Patient Type
    • 10.2.5.3.3. By End User
    • 10.2.5.3.4. By Indication
    • 10.2.5.4. South Korea
    • 10.2.5.4.1. By Product Type
    • 10.2.5.4.2. By Patient Type
    • 10.2.5.4.3. By End User
    • 10.2.5.4.4. By Indication
    • 10.2.5.5. Australia & New Zealand
    • 10.2.5.5.1. By Product Type
    • 10.2.5.5.2. By Patient Type
    • 10.2.5.5.3. By End User
    • 10.2.5.5.4. By Indication
    • 10.2.5.6. Indonesia
    • 10.2.5.6.1. By Product Type
    • 10.2.5.6.2. By Patient Type
    • 10.2.5.6.3. By End User
    • 10.2.5.6.4. By Indication
    • 10.2.5.7. Malaysia
    • 10.2.5.7.1. By Product Type
    • 10.2.5.7.2. By Patient Type
    • 10.2.5.7.3. By End User
    • 10.2.5.7.4. By Indication
    • 10.2.5.8. Singapore
    • 10.2.5.8.1. By Product Type
    • 10.2.5.8.2. By Patient Type
    • 10.2.5.8.3. By End User
    • 10.2.5.8.4. By Indication
    • 10.2.5.9. Vietnam
    • 10.2.5.9.1. By Product Type
    • 10.2.5.9.2. By Patient Type
    • 10.2.5.9.3. By End User
    • 10.2.5.9.4. By Indication
    • 10.2.5.10. Rest of APAC
    • 10.2.5.10.1. By Product Type
    • 10.2.5.10.2. By Patient Type
    • 10.2.5.10.3. By End User
    • 10.2.5.10.4. By Indication

11. Latin America Bowel Management Systems Market

• 11.1. Market Size & Forecast, 2019-2030
  • 11.1.1. By Value (USD Billion)
• 11.2. Market Share & Forecast
  • 11.2.1. By Product Type
  • 11.2.2. By Patient Type
  • 11.2.3. By End User
  • 11.2.4. By Indication
  • 11.2.5. By Country
    • 11.2.5.1. Brazil
    • 11.2.5.1.1. By Product Type
    • 11.2.5.1.2. By Patient Type
    • 11.2.5.1.3. By End User
    • 11.2.5.1.4. By Indication
    • 11.2.5.2. Mexico
    • 11.2.5.2.1. By Product Type
    • 11.2.5.2.2. By Patient Type
    • 11.2.5.2.3. By End User
    • 11.2.5.2.4. By Indication
    • 11.2.5.3. Argentina
    • 11.2.5.3.1. By Product Type
    • 11.2.5.3.2. By Patient Type
    • 11.2.5.3.3. By End User
    • 11.2.5.3.4. By Indication
    • 11.2.5.4. Peru
    • 11.2.5.4.1. By Product Type
    • 11.2.5.4.2. By Patient Type
    • 11.2.5.4.3. By End User
    • 11.2.5.4.4. By Indication
    • 11.2.5.5. Rest of LATAM
    • 11.2.5.5.1. By Product Type
    • 11.2.5.5.2. By Patient Type
    • 11.2.5.5.3. By End User
    • 11.2.5.5.4. By Indication

12. Middle East & Africa Bowel Management Systems Market

• 12.1. Market Size & Forecast, 2019-2030
  • 12.1.1. By Value (USD Billion)
• 12.2. Market Share & Forecast
  • 12.2.1. By Product Type
  • 12.2.2. By Patient Type
  • 12.2.3. By End User
  • 12.2.4. By Indication
  • 12.2.5. By Country
    • 12.2.5.1. Saudi Arabia
    • 12.2.5.1.1. By Product Type
    • 12.2.5.1.2. By Patient Type
    • 12.2.5.1.3. By End User
    • 12.2.5.1.4. By Indication
    • 12.2.5.2. UAE
    • 12.2.5.2.1. By Product Type
    • 12.2.5.2.2. By Patient Type
    • 12.2.5.2.3. By End User
    • 12.2.5.2.4. By Indication
    • 12.2.5.3. Qatar
    • 12.2.5.3.1. By Product Type
    • 12.2.5.3.2. By Patient Type
    • 12.2.5.3.3. By End User
    • 12.2.5.3.4. By Indication
    • 12.2.5.4. Kuwait
    • 12.2.5.4.1. By Product Type
    • 12.2.5.4.2. By Patient Type
    • 12.2.5.4.3. By End User
    • 12.2.5.4.4. By Indication
    • 12.2.5.5. South Africa
    • 12.2.5.5.1. By Product Type
    • 12.2.5.5.2. By Patient Type
    • 12.2.5.5.3. By End User
    • 12.2.5.5.4. By Indication
    • 12.2.5.6. Nigeria
    • 12.2.5.6.1. By Product Type
    • 12.2.5.6.2. By Patient Type
    • 12.2.5.6.3. By End User
    • 12.2.5.6.4. By Indication
    • 12.2.5.7. Algeria
    • 12.2.5.7.1. By Product Type
    • 12.2.5.7.2. By Patient Type
    • 12.2.5.7.3. By End User
    • 12.2.5.7.4. By Indication
    • 12.2.5.8. Rest of MEA
    • 12.2.5.8.1. By Product Type
    • 12.2.5.8.2. By Patient Type
    • 12.2.5.8.3. By End User
    • 12.2.5.8.4. By Indication

13. Competitive Landscape

• 13.1. List of Key Players and Their Drive Types
• 13.2. Competitive Benchmarking, By Operating Parameters
• 13.3. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

14. Global Bowel Management Systems Market: Import & Export

15. Impact of Escalating Geopolitical Tensions on Global Bowel Management Systems Market

16. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

• 16.1. Coloplast
• 16.2. Medtronic
• 16.3. Convatec
• 16.4. Hollister Incorporated
• 16.5. B. Braun Melsungen AG
• 16.6. Axonics Inc
• 16.7. Dentsply Sirona
• 16.8. Consure Medical
• 16.9. MBH-International A/S
• 16.10. Renew Medical Inc.
• 16.11. Other Prominent Players

17. Key Strategic Recommendations

18. Research Methodology

• 18.1. Qualitative Research
  • 18.1.1. Primary & Secondary Research
• 18.2. Quantitative Research
• 18.3. Market Breakdown & Data Triangulation
  • 18.3.1. Secondary Research
  • 18.3.2. Primary Research
• 18.4. Breakdown of Primary Research Respondents, By Region
• 18.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable